首页> 美国卫生研究院文献>other >New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1
【2h】

New Insights Into the Regulation of Natural-Killer Group 2 Member D (NKG2D) and NKG2D-Ligands: Endoplasmic Reticulum Stress and CEA-Related Cell Adhesion Molecule 1

机译:天然杀手组2成员D(NKG2D)和NKG2D配体调控的新见解:内质网应激和CEA相关的细胞粘附分子1

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Natural-killer group 2 member D (NKG2D) is a well-characterized activating receptor expressed by natural killer (NK) cells, NKT cells, activated CD8+ T cells, subsets of γδ+ T cells, and innate-like T cells. NKG2D recognizes multiple ligands (NKG2D-ligands) to mount an innate immune response against stressed, transformed, or infected cells. NKG2D-ligand surface expression is tightly restricted on healthy cells through transcriptional and post-transcriptional mechanisms, while transformed or infected cells express the ligands as a danger signal. Recent studies have revealed that unfolded protein response pathways during endoplasmic reticulum (ER) stress result in upregulation of ULBP-related protein via the protein kinase RNA-like ER kinase-activating factor 4-C/EBP homologous protein (PERK-ATF4-CHOP) pathway, which can be linked to the pathogenesis of autoimmune diseases. Transformed cells, however, possess mechanisms to escape NKG2D-mediated immune surveillance, such as upregulation of carcinoembryonic antigen (CEA)-related cell adhesion molecule 1 (CEACAM1), a negative regulator of NKG2D-ligands. In this review, we discuss mechanisms of NKG2D-ligand regulation, with a focus on newly discovered mechanisms that promote NKG2D-ligand expression on epithelial cells, including ER stress, and mechanisms that suppress NKG2D-ligand-mediated killing of cancer cells, namely by co-expression of CEACAM1.
机译:自然杀伤剂组2成员D(NKG2D)是由自然杀伤(NK)细胞,NKT细胞,活化的CD8 + T细胞,γδ + < / s> T细胞和先天性T细胞。 NKG2D识别多个配体(NKG2D-配体),以针对应激,转化或感染的细胞发起先天免疫应答。 NKG2D配体的表面表达通过转录和转录后机制严格限制在健康细胞上,而转化或感染的细胞则将配体表达为危险信号。最近的研究表明,在内质网(ER)应激期间未表达的蛋白应答途径会通过蛋白激酶RNA样ER激酶激活因子4-C / EBP同源蛋白(PERK-ATF4-CHOP)导致ULBP相关蛋白上调。途径,可以与自身免疫性疾病的发病机制相关。但是,转化细胞具有逃避NKG2D介导的免疫监视的机制,例如上调癌胚抗原(CEA)相关的细胞粘附分子1(CEACAM1),这是NKG2D配体的负调节剂。在这篇综述中,我们讨论了NKG2D-配体调节的机制,重点是新发现的促进NKG2D-配体在上皮细胞上表达的机制,包括内质网应激,以及抑制NKG2D-配体介导的癌细胞杀伤的机制,即通过CEACAM1的共表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号